| Term 
 | Definition 
 
        | The specific compound's structure (usually long and difficult to pronounce) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Official or "nonproprietary" name Shorter
 MAY derive from chemical name
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Phamaceutical company names the drug Doesn't resemble generic or chemical name
 |  | 
        |  | 
        
        | Term 
 
        | What is the study of pharmacology? |  | Definition 
 
        | The study of the effects of chemicals on living organisms |  | 
        |  | 
        
        | Term 
 
        | What is the study of pharmacology for PTs? |  | Definition 
 
        | The study and evaluation of the use of drugs in humans and some animals as it RELATES TO ACTIVITY |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | It's a substance that -alters physiologic functions
 -is used for diagnosis, treatment, or prevention of a disease
 |  | 
        |  | 
        
        | Term 
 
        | What is pharmacotherapeutics? |  | Definition 
 
        | It refers to the use of specific drugs to prevent, treat, or diagnose a disease |  | 
        |  | 
        
        | Term 
 
        | What is pharmacokinetics? |  | Definition 
 
        | How the body deals with drug absorption, distribution, and elimination |  | 
        |  | 
        
        | Term 
 
        | What is pharmacodynamics? |  | Definition 
 
        | Analysis of what drug does to the body including mechanisms by which the drug exerts its effects |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Study of harmful effects of drugs |  | 
        |  | 
        
        | Term 
 
        | What is more expensive? Generic or brand-name drugs? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | T/F: Generic drugs must contain the same active ingredients as the brand-name drug. |  | Definition 
 
        | TRUE- a generic drug may actually even be substituted for the corresponding brand-made drug |  | 
        |  | 
        
        | Term 
 
        | Who monitors the use of existing drugs and develops and approves new drugs? |  | Definition 
 
        | Food and Drug Administration (FDA) |  | 
        |  | 
        
        | Term 
 
        | What is the FDA concerned about when approving and monitoring drugs? |  | Definition 
 
        | 1) Is the drug effective in treating a certain condition? 2) Is the drug reasonably safe for human use?
 |  | 
        |  | 
        
        | Term 
 
        | What are preclinical studies? |  | Definition 
 
        | Animal studies that determine 1) Basic pharmacokinetics and pharmacodynamics properties
 2) Dosage and toxicity
 |  | 
        |  | 
        
        | Term 
 
        | What does the pharma company do after preclinical studies? |  | Definition 
 
        | Files an Investigational New Drug Application (IND) with the FDA |  | 
        |  | 
        
        | Term 
 
        | What is phase 1 of drug approval? |  | Definition 
 
        | Small numbers (20-80) healthy volunteers determine pharmacologic actions & toxic effects
 |  | 
        |  | 
        
        | Term 
 
        | What is phase 2 of drug approval? |  | Definition 
 
        | Small sample (200-300) WITH specific disease or condition to evaluate effectiveness, side effects, and other risks
 |  | 
        |  | 
        
        | Term 
 
        | What is phase 3 of drug approval? |  | Definition 
 
        | Hundreds/thousands with the disease or condition to obtain safety and effectiveness data |  | 
        |  | 
        
        | Term 
 
        | How long does testing take? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What happens after Phase 3 of drug approval? |  | Definition 
 
        | The company submits a New Drug Application (NDA). FDA reviews data extensively. If FDA approves, drug can be marketed and prescribed for use in general population |  | 
        |  | 
        
        | Term 
 
        | How is drug safety and effectiveness monitored after NDA approval? |  | Definition 
 
        | -Reports from health care providers - Obtaining info. on how drug is used in clinical practice
 - Monitoring how the drug compares to similar drugs
 |  | 
        |  | 
        
        | Term 
 
        | What are Over the counter medications? |  | Definition 
 
        | Drugs that may be sold w/o prescription |  | 
        |  | 
        
        | Term 
 
        | What are prescription only medications? |  | Definition 
 
        | Drugs that require prescription from a properly credentialed healthcare practitioner |  | 
        |  | 
        
        | Term 
 
        | What are controlled substances? |  | Definition 
 
        | Both legal and illegal drugs- these are based on potential for abuse |  | 
        |  | 
        
        | Term 
 
        | Describe Over the Counter drugs. |  | Definition 
 
        | 1) Treats minor conditions 2) Easily obtained
 3) Less expensive
 4) Safe since chances of toxic effects are now, abuse potential is low
 |  | 
        |  | 
        
        | Term 
 
        | Describe prescription drugs |  | Definition 
 
        | FDA Authorized by a healthcare practitioner. Also referred to as Legend drugs.
 |  | 
        |  | 
        
        | Term 
 
        | What are schedule I drugs? |  | Definition 
 
        | -highest abuse potential -not acceptable medical treatment in US
 -Tetrahydrocannabinol (THC) is an exception
 |  | 
        |  | 
        
        | Term 
 
        | What are schedule II drugs? |  | Definition 
 
        | -High potential for abuse and addiction - Approved for therapeutic purposes
 -ex. morphine, methamphetamine
 -Strict control prescribing
 |  | 
        |  | 
        
        | Term 
 
        | What are schedule III drugs? |  | Definition 
 
        | - Lower abuse potential but still a mild-moderate physical dependence, strong psychological dependence, or both -ex. codeine /anabolic steroids
 |  | 
        |  | 
        
        | Term 
 
        | What are schedule IV drugs? |  | Definition 
 
        | Lower abuse potential than schedule III Limited physical and/or psychological dependence
 Ex. Diazepam or phenobarbital
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Lowest relative abuse potential |  | 
        |  |